Aerasyn Biotech

Aerasyn is a biotechnology company specializing in cell-free protein synthesis (CFPS) to streamline the production of complex biologics. The company's platform removes the limitations of traditional cell-based manufacturing, allowing for faster design-build-test cycles and the production of proteins that are often toxic or difficult to express in living organisms. Aerasyn aims to apply its technology across various sectors, including therapeutic protein discovery, vaccine manufacturing, and decentralized production. The company was founded by leaders in synthetic biology to address bottlenecks in the biologics supply chain. Its technology enables high-yield production of recombinant proteins and conjugate vaccines in a matter of hours rather than weeks.